Massachusetts Financial Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$717M Buy
10,996,572
+1,911,044
+21% +$153M 0.24% 109
2025
Q4
$866M Sell
9,085,528
-1,281,765
-12% -$126M 0.28% 97
2025
Q3
$1.01B Sell
10,367,293
-2,491,865
-19% -$258M 0.31% 90
2025
Q2
$1.38B Sell
12,859,158
-3,662,461
-22% -$371M 0.44% 65
2025
Q1
$1.67B Sell
16,521,619
-3,138,336
-16% -$316M 0.55% 50
2024
Q4
$1.76B Sell
19,659,955
-6,007,738
-23% -$529M 0.55% 43
2024
Q3
$2.15B Sell
25,667,693
-6,117,525
-19% -$482M 0.64% 33
2024
Q2
$2.45B Sell
31,785,218
-14,821,798
-32% -$1.08B 0.75% 24
2024
Q1
$3.19B Sell
46,607,016
-10,568,954
-18% -$680M 0.95% 17
2023
Q4
$3.31B Sell
57,175,970
-5,357,412
-9% -$286M 1.07% 13
2023
Q3
$3.3B Sell
62,533,382
-6,603,703
-10% -$346M 1.16% 14
2023
Q2
$3.74B Sell
69,137,085
-10,396,546
-13% -$543M 1.23% 11
2023
Q1
$3.98B Sell
79,533,631
-2,450,247
-3% -$115M 1.36% 10
2022
Q4
$3.79B Sell
81,983,878
-2,107,674
-3% -$91.3M 1.32% 10
2022
Q3
$3.26B Buy
84,091,552
+485,936
+0.6% +$19.5M 1.22% 11
2022
Q2
$3.12B Sell
83,605,616
-563,369
-0.7% -$22.9M 1.07% 16
2022
Q1
$3.73B Sell
84,168,985
-1,365,490
-2% -$59.2M 1.1% 15
2021
Q4
$3.63B Buy
85,534,475
+1,738,853
+2% +$73.1M 0.99% 18
2021
Q3
$3.64B Sell
83,795,622
-627,678
-0.7% -$27.8M 1.06% 17
2021
Q2
$3.61B Buy
84,423,300
+1,763,829
+2% +$74.2M 1.05% 18
2021
Q1
$3.19B Buy
82,659,471
+33,630,705
+69% +$1.27B 0.98% 20
2020
Q4
$1.76B Buy
49,028,766
+5,703,310
+13% +$206M 0.57% 47
2020
Q3
$1.66B Buy
43,325,456
+306,813
+0.7% +$11.8M 0.6% 40
2020
Q2
$1.51B Buy
43,018,643
+13,284,649
+45% +$478M 0.6% 42
2020
Q1
$970M Buy
29,733,994
+16,151,261
+119% +$631M 0.46% 63
2019
Q4
$614M Buy
13,582,733
+1,354,675
+11% +$56.7M 0.23% 108
2019
Q3
$498M Buy
12,228,058
+623,179
+5% +$26.4M 0.2% 122
2019
Q2
$499M Buy
11,604,879
+220,156
+2% +$8.47M 0.2% 119
2019
Q1
$437M Buy
11,384,723
+3,439,762
+43% +$131M 0.18% 126
2018
Q4
$281M Buy
7,944,961
+4,941,897
+165% +$179M 0.13% 153
2018
Q3
$116M Buy
+3,003,064
New +$105M 0.05% 264
2015
Q2
Sell
-1,042,321
Closed -$18.5M 888
2015
Q1
$18.5M Buy
+1,042,321
New +$16.5M 0.01% 545

Other funds holding BSX

Massachusetts Financial Services's BSX Position: Q1 2026 in Review

Massachusetts Financial Services increased its Boston Scientific (BSX) stake by 21% in Q1 2026, buying an estimated $153M and bringing the position to 10,996,572 shares worth $717M. The position accounts for 0.24% of the portfolio, ranked #109.

Massachusetts Financial Services first reported a position in BSX in Q1 2015 and has held it in 32 quarters since. The position peaked at $3.98B in Q1 2023. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Massachusetts Financial Services held 10,996,572 shares of Boston Scientific worth $717M as of Q1 2026.
  • Massachusetts Financial Services bought 1,911,044 Boston Scientific shares in Q1 2026, an estimated $153M.
  • Boston Scientific made up 0.24% of Massachusetts Financial Services's portfolio in Q1 2026, its #109 holding.
  • Massachusetts Financial Services first reported a position in Boston Scientific in Q1 2015 and has held it in 32 quarters since.
  • Massachusetts Financial Services's Boston Scientific position peaked at $3.98B in Q1 2023.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.